MDxHealth S.A. (MDXH) vs Scilex Holding Company (SCLX)
A side-by-side comparison of MDxHealth S.A. and Scilex Holding Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDXH
MDxHealth S.A.
$0.60HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
SCLX
Scilex Holding Company
$3.95HealthcareDelayed quote: Oct 6, 2026, 3:03 PM EDT
Total return — MDXH vs SCLX
growth of $100 · dividends reinvested · last 5yMDXH -95.0% (-45.1%/yr)SCLX -98.9% (-59.6%/yr)MDXH compounded faster over this window
MDXH SCLX
MDXH vs SCLX: by the numbers
- •SCLX is the larger company ($34M vs $31M market cap).
- •Both run net losses; MDXH's is the smaller (-31.07% vs -1414.57% net margin).
- •MDXH grew revenue faster over the past five years (42.35% vs 3.58% CAGR).
Metrics side by side
Valuation
| Metric | MDXH | SCLX |
|---|---|---|
| P/S ratio | N/A | 1.06 |
Profitability
| Metric | MDXH | SCLX |
|---|---|---|
| Gross margin | 59.74% | 49.68% |
| Operating margin | -14.28% | -903.52% |
| Net margin | -31.07% | -1414.57% |
| ROIC | -15.35% | N/A |
Growth (annualized)
| Metric | MDXH | SCLX |
|---|---|---|
| Revenue CAGR (5Y) | 42.35% | 3.58% |
| Total return CAGR (5Y) | N/A | -59.50% |
Frequently asked
- Which has grown faster, MDXH or SCLX?
- Over the past five years, MDXH grew revenue faster — MDXH at a 42.35% CAGR versus SCLX at 3.58%.
Go deeper
Dig into the metrics
MDxHealth ROEScilex ROEMDxHealth operating marginScilex operating marginMDxHealth revenue growthScilex revenue growthMDxHealth free cash flowScilex free cash flow
MDxHealth & Scilex appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.